ATE485050T1 - Verwendung von p43 zur förderung der wundheilung - Google Patents
Verwendung von p43 zur förderung der wundheilungInfo
- Publication number
- ATE485050T1 ATE485050T1 AT03016724T AT03016724T ATE485050T1 AT E485050 T1 ATE485050 T1 AT E485050T1 AT 03016724 T AT03016724 T AT 03016724T AT 03016724 T AT03016724 T AT 03016724T AT E485050 T1 ATE485050 T1 AT E485050T1
- Authority
- AT
- Austria
- Prior art keywords
- wound healing
- polypeptide
- promote wound
- epithelialization
- monocyte
- Prior art date
Links
- 230000029663 wound healing Effects 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2002-0042858A KR100515016B1 (ko) | 2002-07-22 | 2002-07-22 | p43을 유효성분으로 하는 창상 치료용 약학적 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE485050T1 true ATE485050T1 (de) | 2010-11-15 |
Family
ID=29997531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03016724T ATE485050T1 (de) | 2002-07-22 | 2003-07-22 | Verwendung von p43 zur förderung der wundheilung |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US7282208B2 (de) |
| EP (1) | EP1384486B1 (de) |
| KR (1) | KR100515016B1 (de) |
| AT (1) | ATE485050T1 (de) |
| DE (1) | DE60334589D1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100515016B1 (ko) * | 2002-07-22 | 2005-09-15 | 재단법인서울대학교산학협력재단 | p43을 유효성분으로 하는 창상 치료용 약학적 조성물 |
| EP1848395A4 (de) * | 2005-02-01 | 2012-06-06 | Atyr Pharma Inc | Verfahren zur stimulierung der collagensynthese und/oder kgf-expression |
| AU2006335748A1 (en) | 2006-01-23 | 2007-07-26 | Imagene Co., Ltd. | Novel peptide and use thereof |
| WO2008007818A1 (en) * | 2006-07-13 | 2008-01-17 | Seoul National University Industry Foundation | Novel use of aimp1 for controlling glucose level |
| JP2010526527A (ja) * | 2007-02-01 | 2010-08-05 | イマジーン・カンパニー・リミテッド | 抗腫瘍活性を有する新規なポリペプチド |
| KR101067817B1 (ko) * | 2008-10-10 | 2011-09-27 | 서울대학교산학협력단 | Aimp1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물 |
| ES2552773T3 (es) | 2009-02-27 | 2015-12-02 | Atyr Pharma, Inc. | Motivos estructurales de polipéptidos asociados con la actividad de señalización celular |
| JP5730280B2 (ja) | 2009-03-16 | 2015-06-03 | パング バイオファーマ リミテッド | 非カノニカル生物学的活性を有するヒスチジル−tRNAシンテターゼスプライスバリアントを含む組成物および方法 |
| ES2535951T3 (es) | 2009-12-11 | 2015-05-19 | Atyr Pharma, Inc. | Histidil ARNt sintetasas para reducir la inflamación |
| EP2593126B1 (de) | 2010-07-12 | 2017-09-20 | aTyr Pharma, Inc. | Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von histidyl-trna-synthetasen |
| US10279007B2 (en) | 2010-11-15 | 2019-05-07 | Oxygenetix Institute, Inc. | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs |
| WO2013022982A2 (en) | 2011-08-09 | 2013-02-14 | Atyr Pharma, Inc. | Pegylated tyrosyl-trna synthetase polypeptides |
| WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
| US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
| CN104220461A (zh) | 2011-12-29 | 2014-12-17 | Atyr医药公司 | 天冬氨酰-tRNA合成酶-FC缀合物 |
| EP2814514B1 (de) | 2012-02-16 | 2017-09-13 | Atyr Pharma, Inc. | Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen |
| CN114717206A (zh) | 2013-03-15 | 2022-07-08 | Atyr 医药公司 | 组氨酰-trna合成酶-fc缀合物 |
| JP6521995B2 (ja) | 2014-02-20 | 2019-05-29 | ユニヴァーシティー オブ ノートル ダム デュ ラック | 選択的マトリックスメタロプロテイナーゼ阻害剤 |
| WO2016044844A1 (en) | 2014-09-19 | 2016-03-24 | University Of Notre Dame Du Lac | Acceleration of diabetic wound healing |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641867A (en) * | 1993-09-29 | 1997-06-24 | The Trustees Of Columbia University In The City Of New York | Antibody which specifically binds to endothelial-monocyte activating polypeptide II |
| US6391311B1 (en) * | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| CA2340468A1 (en) * | 1998-11-13 | 2000-05-25 | Children's Hospital Of Los Angeles | Methods of facilitating vascular growth |
| AU5114000A (en) * | 2000-06-14 | 2001-12-24 | Imagene Co., Ltd. | P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain |
| KR100405919B1 (ko) * | 2001-06-05 | 2003-11-14 | 주식회사 이매진 | p43의 N-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물 |
| KR100515016B1 (ko) * | 2002-07-22 | 2005-09-15 | 재단법인서울대학교산학협력재단 | p43을 유효성분으로 하는 창상 치료용 약학적 조성물 |
-
2002
- 2002-07-22 KR KR10-2002-0042858A patent/KR100515016B1/ko not_active Expired - Fee Related
-
2003
- 2003-07-22 US US10/623,567 patent/US7282208B2/en not_active Expired - Fee Related
- 2003-07-22 AT AT03016724T patent/ATE485050T1/de not_active IP Right Cessation
- 2003-07-22 EP EP03016724A patent/EP1384486B1/de not_active Expired - Lifetime
- 2003-07-22 DE DE60334589T patent/DE60334589D1/de not_active Expired - Lifetime
-
2007
- 2007-07-26 US US11/829,018 patent/US7572452B2/en not_active Expired - Fee Related
-
2009
- 2009-08-10 US US12/538,714 patent/US7981426B2/en not_active Expired - Fee Related
-
2011
- 2011-06-08 US US13/155,750 patent/US20120010141A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1384486A1 (de) | 2004-01-28 |
| DE60334589D1 (de) | 2010-12-02 |
| US7282208B2 (en) | 2007-10-16 |
| US20080064627A1 (en) | 2008-03-13 |
| US20100041608A1 (en) | 2010-02-18 |
| EP1384486B1 (de) | 2010-10-20 |
| US7572452B2 (en) | 2009-08-11 |
| US7981426B2 (en) | 2011-07-19 |
| KR20040009048A (ko) | 2004-01-31 |
| KR100515016B1 (ko) | 2005-09-15 |
| US20120010141A1 (en) | 2012-01-12 |
| US20050119175A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60334589D1 (de) | Verwendung von p43 zur Förderung der Wundheilung | |
| ATE540973T1 (de) | Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung | |
| ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
| DE69018920D1 (de) | Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine. | |
| DK2107109T3 (da) | Rekombinant vaskulær endotelcelle-vækstfaktor D (VEGF-D) | |
| DE69828193D1 (de) | Hyaluronan synthase gen und seine verwendung | |
| DK1032671T3 (da) | Mammalt cytokin-lignende polypeptid-10 | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| ATE382685T1 (de) | Bakteriophagen-lysin | |
| DE69132530D1 (de) | Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf) | |
| DE68929430D1 (de) | Fibronektin bindendes Protein | |
| DE50015938D1 (de) | Polypeptidvarianten mit erhoehter heparin-bindungsfaehigkeit | |
| DE60234822D1 (de) | Lipoxygenase-varianten und ihre verwendung | |
| MX2009008270A (es) | Polipeptido novedoso que tiene actividad anti-tumoral. | |
| ATE246247T1 (de) | Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
| ATE455792T1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
| DE69821793D1 (de) | Neuronale verwendungen des bmp-11 | |
| ATE482272T1 (de) | Zytokinproteinfamilie | |
| ES2177625T3 (es) | Citoquina cc-1 humana circulante. | |
| ATE291088T1 (de) | Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe | |
| DE602004023340D1 (de) | Onkogen, davon abgeleitetes rekombinantes Protein und dessen Verwendung | |
| NO20001077L (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister | |
| ATE251640T1 (de) | Neues chondrozytprotein | |
| DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |